EP1158991A4 - Traitement de l'asthme - Google Patents
Traitement de l'asthmeInfo
- Publication number
- EP1158991A4 EP1158991A4 EP00911507A EP00911507A EP1158991A4 EP 1158991 A4 EP1158991 A4 EP 1158991A4 EP 00911507 A EP00911507 A EP 00911507A EP 00911507 A EP00911507 A EP 00911507A EP 1158991 A4 EP1158991 A4 EP 1158991A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- asthma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ33466499 | 1999-03-15 | ||
NZ33466499 | 1999-03-15 | ||
PCT/NZ2000/000027 WO2000054783A1 (fr) | 1999-03-15 | 2000-03-15 | Traitement de l'asthme |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1158991A1 EP1158991A1 (fr) | 2001-12-05 |
EP1158991A4 true EP1158991A4 (fr) | 2003-05-14 |
Family
ID=19927171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00911507A Withdrawn EP1158991A4 (fr) | 1999-03-15 | 2000-03-15 | Traitement de l'asthme |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1158991A4 (fr) |
AU (1) | AU3337300A (fr) |
CA (1) | CA2367447A1 (fr) |
WO (1) | WO2000054783A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1649869A1 (fr) * | 2004-10-21 | 2006-04-26 | Vakzine Projekt Management GmbH | Combinaison d'une mycobacterie et d'un agent biologiquement actif comme vaccin |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997034149A1 (fr) * | 1996-03-12 | 1997-09-18 | Stefan Svenson | Methode diagnostique de mycobacteriose et trousse d'essai immunologique |
US5853737A (en) * | 1992-12-10 | 1998-12-29 | Brigham And Women's Hospital | Method for inducing a CD1-restricted immune response |
-
2000
- 2000-03-15 WO PCT/NZ2000/000027 patent/WO2000054783A1/fr not_active Application Discontinuation
- 2000-03-15 CA CA002367447A patent/CA2367447A1/fr not_active Abandoned
- 2000-03-15 AU AU33373/00A patent/AU3337300A/en not_active Abandoned
- 2000-03-15 EP EP00911507A patent/EP1158991A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5853737A (en) * | 1992-12-10 | 1998-12-29 | Brigham And Women's Hospital | Method for inducing a CD1-restricted immune response |
WO1997034149A1 (fr) * | 1996-03-12 | 1997-09-18 | Stefan Svenson | Methode diagnostique de mycobacteriose et trousse d'essai immunologique |
Non-Patent Citations (1)
Title |
---|
See also references of WO0054783A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1158991A1 (fr) | 2001-12-05 |
AU3337300A (en) | 2000-10-04 |
CA2367447A1 (fr) | 2000-09-21 |
WO2000054783A1 (fr) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2351661B (en) | Novel method of treatment | |
GB9824436D0 (en) | Methods of treatment | |
IL145875A0 (en) | Novel method of treatment | |
EP1239851A4 (fr) | Traitement des troubles hyperproliferatifs | |
NZ513686A (en) | Treatment of trauma | |
GB9924141D0 (en) | Treatment of gastric asthma | |
EP1225919A4 (fr) | Traitement du cancer | |
GB9930688D0 (en) | Novel method of treatment | |
PL350963A1 (en) | Use of arylalkanoylpyridazines | |
EP1158991A4 (fr) | Traitement de l'asthme | |
NZ513823A (en) | Treatment of asthma | |
EP1303281A4 (fr) | Methodes de traitement | |
HU9802379D0 (en) | Inhaler for treatment of asthma | |
AUPQ361499A0 (en) | Treatment of asthma | |
AUPQ373899A0 (en) | Treatment of asthma II | |
GB9901310D0 (en) | Methods of treatment | |
GB9917181D0 (en) | Methods of treatment | |
GB9930696D0 (en) | Novel method of treatment | |
IL145242A0 (en) | Treatment of hiatial hernia | |
EP1165060A4 (fr) | Traitement des calculs biliaires | |
GB9911183D0 (en) | Treatment of cancers | |
GB9926359D0 (en) | Treatment of alopecia | |
GB9930689D0 (en) | Novel method of treatment | |
GB0122638D0 (en) | Novel method of treatment | |
GB9930692D0 (en) | Novel method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011003 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: THE UNIVERSITY OF OTAGO Owner name: AGRESEARCH LIMITED Owner name: THE MALAGHAN INSTITUTE OF MEDICAL RESEARCH |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030328 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 31/739 A Ipc: 7A 61P 11/06 B Ipc: 7A 61K 35/74 B Ipc: 7A 61P 37/08 B |
|
17Q | First examination report despatched |
Effective date: 20040204 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040615 |